Generic cyclosporine formulations: more open questions than answers
2005-01-01 Cattaneo, D; Perico, N; Remuzzi, G
Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer
2007-01-01 Ripamonti, Diego; Cattaneo, D; Maggiolo, Franco; Airoldi, Monica; Frigerio, Luigi; Bertuletti, Pierangelo; Ruggeri, Maurizio; Suter, Fredy
Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samples
2022-01-01 Baldelli, S; Cerea, M; Mangioni, D; Alagna, L; Muscatello, A; Bandera, A; Cattaneo, D
Atazanavir-induced severe episodes of kidney stones in an HIV-1-infected subject characterized by a CYP3A poor metabolizer phenotype
2014-01-01 Rusconi, S.; Gagliardini, R.; Falvella, F. S.; Cattaneo, D.; Di Cristo, V.; De Luca, A.; Fabbiani, M.; Clementi, E.; Galli, M.; Di Giambenedetto, S.
Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients
2016-01-01 Ferretti, F; Bigoloni, A; Passeri, L; Galli, L; Longo, V; Gerevini, S; Spagnuolo, V; Gisslen, M; Zetterberg, H; Fuchs, D; Cattaneo, D; Caramatti, G; Lazzarin, A; Cinque, P; Castagna, A.
Case of Suboptimal Linezolid Exposure: Is There a Role for Pharmacogenetics?
2020-01-01 Baldelli, S; Montrasio, C; Cheli, S; Viganò, O; Bini, T; Egidi, M; Cattaneo, D
Lacosamide effectiveness and tolerability in patients with drug-resistant epilepsy and severe disability under polytherapy: Therapy optimization as emerging from an observational study
2022-01-01 Pozzi, M; Zanotta, N; Epifanio, R; Baldelli, S; Cattaneo, D; Clementi, E; Zucca, C
Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients?
2021-01-01 Maggiore, U; Palmisano, A; Buti, S; Claire Giudice, G; Cattaneo, D; Giuliani, N; Fiaccadori, E; Gandolfini, I; Cravedi, P.
One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study
2023-01-01 Cheli, S; Savino, D; De Silvestri, A; Norsa, L; Sansotta, N; Penagini, F; Dilillo D, ; Panceri, R; Cattaneo, D; Clementi, E; Zuin, G
Therapeutic drug monitoring and pharmacogenetics of antipsychotics and antidepressants in real life settings: A 5-year single centre experience
2020-01-01 Baldelli, S.; Cheli, S.; Montrasio, C.; Cattaneo, D.; Clementi, E.
Optimizing antibiotic therapy for intravenous drug users: a narrative review unraveling pharmacokinetics/pharmacodynamics challenges
2024-01-01 Colaneri, Marta; Genovese, Camilla; Valsecchi, Pietro; Calia, Matteo; Cattaneo, Dario; Gori, Andrea; Bruno, Raffaele; Seminari, Elena
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients
2021-01-01 Falcone, M; Menichetti, F; Cattaneo, D; Tiseo, G; Baldelli, S; Galfo, V; Leonildi A, ; Tagliaferri, E; Di Paolo, A; Pai, Mp.
Is chewed raltegravir an option to care for HIV-infected patients with active tuberculosis?
2013-01-01 Gervasoni, C.; Riva, A.; Impagnatiello, C.; Galli, M.; Cattaneo, D.
Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose?
2020-01-01 Baldelli, S; Corbellino, M; Clementi, E; Cattaneo, D; Gervasoni, C.
Determinants of bone diseases in tenofovir-treated HIV patients
2016-01-01 Gervasoni, C.; Minisci, D.; Meraviglia, P.; Baldelli, S.; Clementi, E.; Rizzardini, G.; Cattaneo, D.
Comparison of the Innofluor (R) certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation
2006-01-01 Baldelli, Sara; Crippa, Alberto; Gabrieli, Roberta; Fiocchi, Roberto; Perico, Norberto; Merlini, Simona; Ottomano, Cosimo; Cattaneo, D
Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects
2012-01-01 Cattaneo, D; Gervasoni, Cristina; Meraviglia, Paola; Landonio, Simona; Fucile, Serena; Cozzi, Valeria; Baldelli, Sara; Pellegrini, Michela; Galli, Massimo; Clementi, Emilio
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy
2018-01-01 Giacomelli, A; Riva, A; Falvella, Fs; Oreni, Ml; Cattaneo, D; Cheli, S; Renisi, G; Di Cristo, V; Lupo, A; Clementi, E; Rusconi, S; Galli, M; Ridolfo, Al
Therapeutic Drug Monitoring of Dalbavancin Treatment in Severe Necrotizing Fasciitis in 3 Critically Ill Patients: A Grand Round
2020-01-01 Corona, A; Agarossi, A; Veronese, A; Cattaneo, D; Dʼavolio, A
Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers : a randomized, open-label, 2-period, single-dose, crossover phase 1 study
2015-01-01 Cattaneo, D.; Cossu, M. V.; Fucile, S.; Riva, A.; Baldelli, S.; Meraviglia, P.; Landonio, S.; Impagnatiello, C.; Resnati, C.; Galli, M.; Clementi, E.; Capetti, A.; Rizzardini, G.; Gervasoni, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Generic cyclosporine formulations: more open questions than answers | 1-gen-2005 | Cattaneo, D; Perico, N; Remuzzi, G | |
| Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer | 1-gen-2007 | Ripamonti, Diego; Cattaneo, D; Maggiolo, Franco; Airoldi, Monica; Frigerio, Luigi; Bertuletti, Pierangelo; Ruggeri, Maurizio; Suter, Fredy | |
| Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samples | 1-gen-2022 | Baldelli, S; Cerea, M; Mangioni, D; Alagna, L; Muscatello, A; Bandera, A; Cattaneo, D | |
| Atazanavir-induced severe episodes of kidney stones in an HIV-1-infected subject characterized by a CYP3A poor metabolizer phenotype | 1-gen-2014 | Rusconi, S.; Gagliardini, R.; Falvella, F. S.; Cattaneo, D.; Di Cristo, V.; De Luca, A.; Fabbiani, M.; Clementi, E.; Galli, M.; Di Giambenedetto, S. | |
| Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients | 1-gen-2016 | Ferretti, F; Bigoloni, A; Passeri, L; Galli, L; Longo, V; Gerevini, S; Spagnuolo, V; Gisslen, M; Zetterberg, H; Fuchs, D; Cattaneo, D; Caramatti, G; Lazzarin, A; Cinque, P; Castagna, A. | |
| Case of Suboptimal Linezolid Exposure: Is There a Role for Pharmacogenetics? | 1-gen-2020 | Baldelli, S; Montrasio, C; Cheli, S; Viganò, O; Bini, T; Egidi, M; Cattaneo, D | |
| Lacosamide effectiveness and tolerability in patients with drug-resistant epilepsy and severe disability under polytherapy: Therapy optimization as emerging from an observational study | 1-gen-2022 | Pozzi, M; Zanotta, N; Epifanio, R; Baldelli, S; Cattaneo, D; Clementi, E; Zucca, C | |
| Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients? | 1-gen-2021 | Maggiore, U; Palmisano, A; Buti, S; Claire Giudice, G; Cattaneo, D; Giuliani, N; Fiaccadori, E; Gandolfini, I; Cravedi, P. | |
| One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study | 1-gen-2023 | Cheli, S; Savino, D; De Silvestri, A; Norsa, L; Sansotta, N; Penagini, F; Dilillo D, ; Panceri, R; Cattaneo, D; Clementi, E; Zuin, G | |
| Therapeutic drug monitoring and pharmacogenetics of antipsychotics and antidepressants in real life settings: A 5-year single centre experience | 1-gen-2020 | Baldelli, S.; Cheli, S.; Montrasio, C.; Cattaneo, D.; Clementi, E. | |
| Optimizing antibiotic therapy for intravenous drug users: a narrative review unraveling pharmacokinetics/pharmacodynamics challenges | 1-gen-2024 | Colaneri, Marta; Genovese, Camilla; Valsecchi, Pietro; Calia, Matteo; Cattaneo, Dario; Gori, Andrea; Bruno, Raffaele; Seminari, Elena | |
| Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients | 1-gen-2021 | Falcone, M; Menichetti, F; Cattaneo, D; Tiseo, G; Baldelli, S; Galfo, V; Leonildi A, ; Tagliaferri, E; Di Paolo, A; Pai, Mp. | |
| Is chewed raltegravir an option to care for HIV-infected patients with active tuberculosis? | 1-gen-2013 | Gervasoni, C.; Riva, A.; Impagnatiello, C.; Galli, M.; Cattaneo, D. | |
| Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose? | 1-gen-2020 | Baldelli, S; Corbellino, M; Clementi, E; Cattaneo, D; Gervasoni, C. | |
| Determinants of bone diseases in tenofovir-treated HIV patients | 1-gen-2016 | Gervasoni, C.; Minisci, D.; Meraviglia, P.; Baldelli, S.; Clementi, E.; Rizzardini, G.; Cattaneo, D. | |
| Comparison of the Innofluor (R) certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation | 1-gen-2006 | Baldelli, Sara; Crippa, Alberto; Gabrieli, Roberta; Fiocchi, Roberto; Perico, Norberto; Merlini, Simona; Ottomano, Cosimo; Cattaneo, D | |
| Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects | 1-gen-2012 | Cattaneo, D; Gervasoni, Cristina; Meraviglia, Paola; Landonio, Simona; Fucile, Serena; Cozzi, Valeria; Baldelli, Sara; Pellegrini, Michela; Galli, Massimo; Clementi, Emilio | |
| Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy | 1-gen-2018 | Giacomelli, A; Riva, A; Falvella, Fs; Oreni, Ml; Cattaneo, D; Cheli, S; Renisi, G; Di Cristo, V; Lupo, A; Clementi, E; Rusconi, S; Galli, M; Ridolfo, Al | |
| Therapeutic Drug Monitoring of Dalbavancin Treatment in Severe Necrotizing Fasciitis in 3 Critically Ill Patients: A Grand Round | 1-gen-2020 | Corona, A; Agarossi, A; Veronese, A; Cattaneo, D; Dʼavolio, A | |
| Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers : a randomized, open-label, 2-period, single-dose, crossover phase 1 study | 1-gen-2015 | Cattaneo, D.; Cossu, M. V.; Fucile, S.; Riva, A.; Baldelli, S.; Meraviglia, P.; Landonio, S.; Impagnatiello, C.; Resnati, C.; Galli, M.; Clementi, E.; Capetti, A.; Rizzardini, G.; Gervasoni, C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista27914
Data di pubblicazione
- In corso di stampa14
- 2020 - 20269649
- 2010 - 201911835
- 2000 - 20094579
- 1990 - 19991485
- 1980 - 1989329
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE372
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...267
- ANNALS OF ONCOLOGY244
- CANCERS232
- PLOS ONE223
- THE JOURNAL OF NUCLEAR MEDICINE222
- JOURNAL OF CLINICAL MEDICINE215
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY197
- ALLERGY180
Keyword
- Humans2166
- Female1035
- Male996
- Middle Aged767
- Aged669
- Adult559
- COVID-19442
- Treatment Outcome373
- Animals329
- Retrospective Studies264
Lingua
- eng19968
- ita459
- spa14
- fre11
- ger8
- enm4
- por2
- chi1
Accesso al fulltext
- no fulltext25661
- reserved1362
- open891